PA MPJE flashcards
PA MPJE · Build recall with a focused review session.
32 cards. Read the term and the definition here. The deck at the top of this page is optional.
- Pennsylvania State Board of Pharmacy
- The state agency within the Department of State that licenses pharmacists and pharmacies, adopts regulations, and disciplines licensees for violations of the Pharmacy Act.
- DEA registration
- Federal registration required for any entity that manufactures, distributes, dispenses, or prescribes controlled substances; it must be renewed and kept at the registered location.
- FDA authority
- Federal agency that approves drugs and regulates manufacturing, labeling, and advertising; it does not license pharmacies or set state scope of practice.
- Pharmacy Act
- Pennsylvania statute governing pharmacy practice, licensure, and Board authority; Board regulations are in Title 49 Pa. Code Chapter 27.
- Pharmacist licensure requirements
- In Pennsylvania, graduation from an ACPE-accredited pharmacy program, required internship hours, NAPLEX and MPJE passage, and Board approval are needed for licensure.
- Pharmacy intern registration
- A pharmacy intern must be registered with the Pennsylvania Board before earning internship hours; the preceptor verifies and reports those hours.
- Pharmacy technician registration
- Pennsylvania requires pharmacy technicians to be registered with the Board; registration permits working under pharmacist supervision but not independent practice.
- Pharmacy permit
- A Board-issued authorization for a specific pharmacy location; changes in ownership or location require Board notification or a new permit.
- Pharmacist-in-charge duties
- The PIC ensures the pharmacy complies with law, maintains records and security, supervises personnel, and is responsible for dispensing quality and patient safety.
- Biennial controlled substance inventory
- A complete count of controlled substances on hand, required every two years by DEA, with records retained for at least two years.
- Theft or loss reporting
- Controlled substance theft or significant loss must be reported to DEA using Form 106 and to the Pennsylvania Board as required.
- Pharmacy security
- The pharmacy must be locked when no pharmacist is present, and only authorized personnel may access prescription and controlled substance storage areas.
- Valid prescription elements
- A prescription must identify the patient, drug, strength, dosage form, quantity, directions, prescriber, date, and signature; controlled substances require additional DEA elements.
- Schedule II refills
- Schedule II prescriptions may not be refilled; emergency oral Schedule II orders require a written prescription within seven days under federal law.
- Prescription transfer
- A pharmacist may transfer prescription information to another pharmacy by pharmacist-to-pharmacist communication, documenting the transfer and canceling the original.
- Prescription label content
- The label must include pharmacy name and address, prescription number, date, patient name, prescriber, directions, drug name and strength, quantity, and expiration or beyond-use date.
- DEA schedules
- Controlled substances are classified I-V by abuse potential and medical use; Schedule I has no accepted medical use, while Schedule V has the lowest abuse potential.
- Schedule III-V refills
- A prescription for a Schedule III, IV, or V controlled substance may be refilled up to five times within six months of the issue date.
- PDMP reporting
- Pennsylvania dispensers must report controlled substance dispensing to the Prescription Drug Monitoring Program within the timeframe set by state regulation, generally 24 hours.
- DEA Form 222
- The order form used to procure Schedule I and II controlled substances; it must be completed and retained, and CSOS may be used electronically.
- Immunization authority
- Pennsylvania pharmacists with required training may administer vaccines under a protocol or standing order to specified age groups and must report doses to the state registry.
- Collaborative practice agreement
- A written agreement between a pharmacist and prescriber that defines the pharmacist's permitted drug therapy management activities, documentation, and communication.
- Naloxone standing order
- Pennsylvania allows pharmacists to dispense naloxone under a standing order or protocol, with training and documentation, to reduce opioid overdose deaths.
- USP 795
- Standards for nonsterile compounding that address facilities, equipment, master formulation records, compounding records, and beyond-use dates.
- USP 797
- Standards for sterile compounding that require cleanrooms, environmental monitoring, trained personnel, and validated processes to prevent contamination.
- Master formulation record
- A document for a compounded preparation that lists ingredients, quantities, equipment, procedure, and beyond-use date; it guides each batch.
- Beyond-use date
- The date after which a compounded preparation must not be used, determined from USP standards, stability, storage, and preservative considerations.
- Patient counseling
- The pharmacist discusses drug name, purpose, directions, storage, common side effects, interactions, and when to seek medical help, and documents refusal.
- HIPAA privacy
- Federal law protecting identifiable health information; pharmacies must safeguard records and provide notice of privacy practices.
- Hospital pharmacy permit
- A Pennsylvania hospital pharmacy must hold a Board permit, have a pharmacist-in-charge, and comply with institutional drug distribution and recordkeeping rules.
- Automated dispensing system
- A device for storing and dispensing drugs in institutional settings; it requires security, accountability, pharmacist oversight, and audit trails.
- Long-term care drug regimen review
- In long-term care, a consultant pharmacist reviews each resident's medication regimen at least monthly and reports irregularities to the attending physician and facility.